ISLAMABAD: Pakistan can count on 17 million doses of the AstraZeneca vaccine towards the coronavirus “before April”, in line with an announcement by the British High Commission.
According to the assertion, an “additional 10 million doses” can be supplied earlier than June.
With the vaccine, greater than eight million individuals will obtain safety from coronavirus, it added.
The chief of the National Command and Operation Centre (NCOC), Asad Umar, had earlier broke the excellent news that COVAX has indicated a provide of as much as 17 million doses of the AstraZeneca coronavirus vaccine for Pakistan within the first half of 2021.
“Good news on COVID vaccine front. Received a letter from COVAX of [an] indicative supply of up to 17 million doses of AstraZeneca in 1st half 2021,” Umar wrote on Twitter.
According to the planning minister, six million of the whole 17 million doses can be obtained by March with supply beginning in February. He didn’t specify any dates.
Soon after, the COVAX programme for COVID-19 vaccines introduced a listing of nations will probably be distributing doses to, with Pakistan to get 17.2 million doses.
The initiative has deliberate sufficient doses for dozens of nations to immunise greater than 3% of their populations by mid-year.
A press release mentioned the preliminary distribution was in keeping with a goal “to protect the most vulnerable groups such as health care workers” within the first half of the yr.
How the AstraZeneca vaccine works
The Oxford-AstraZeneca vaccine is comprised of a weakened model of a typical chilly virus, generally known as adenovirus, from chimpanzees, and has been modified to look extra just like the coronavirus — though it can’t trigger the sickness.
When the vaccine is injected right into a human physique, it prompts the immune system to make antibodies and trains it to assault any coronavirus an infection.
The vaccine requires two doses to be administered.
The jab has been discovered to be 76% efficient towards the unique coronavirus after the primary dose. Research exhibits that when a second dose is given after 12 weeks or extra, the efficacy rises to 82%.
The Oxford-AstraZeneca vaccine is extra appropriate for growing nations as it may be saved in a standard fridge for six months, making it a lot simpler to distribute. It can be cheaper to make.
It was first accepted for emergency use by the United Kingdom authorities.